| 2008 JASN IMPACT FACTOR 7.505 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CLINICAL RESEARCH |









* Department of Nephrology, Dialysis and Renal Transplantation, A. Manzoni Hospital, Lecco, Italy;
Department of Nephrology, University Hospital Reina Sofia, Cordoba, Spain;
Department of Nephrology, University Hospital, Strasbourg, France;
Department of Nephrology, Portuguese Institute of Oncology, Porto, Portugal; || Department of Nephrology, Hippokration General Hospital, Thessaloniki Greece; ¶ Georg-Haas-Dialysis Centre, Giessen, Germany; ** Department of Nephrology, Danderyd University Hospital, Karolinska Institute, Stockholm, Sweden; 
Department of Nephrology, Transplantology and Internal Diseases, Pozna
University of Medical Sciences, Pozna
, Poland; 
Department of Nephrology and Intensive Care, St. Bortolo Hospital, Vincenza, Italy; and 
Department of Internal Medicine, Nephrology Section, University Hospital, Ghent, Belgium
Correspondence: Prof. Francesco Locatelli, Department of Nephrology, Dialysis and Renal Transplantation, A. Manzoni Hospital, Via dell'Eremo 9/11, I-23900 Lecco, Italy. Phone: +39-0341-489850; Fax: +39-0341-489860; E-mail: f.locatelli{at}ospedale.lecco.it
Received for publication June 10, 2008. Accepted for publication September 22, 2008.
The effect of high-flux hemodialysis membranes on patient survival has not been unequivocally determined. In this prospective, randomized clinical trial, we enrolled 738 incident hemodialysis patients, stratified them by serum albumin
4 and >4 g/dl, and assigned them to either low-flux or high-flux membranes. We followed patients for 3 to 7.5 yr. Kaplan-Meier survival analysis showed no significant difference between high-flux and low-flux membranes, and a Cox proportional hazards model concurred. Patients with serum albumin
4 g/dl had significantly higher survival rates in the high-flux group compared with the low-flux group (P = 0.032). In addition, a secondary analysis revealed that high-flux membranes may significantly improve survival of patients with diabetes. Among those with serum albumin
4 g/dl, slightly different effects among patients with and without diabetes suggested a potential interaction between diabetes status and low serum albumin in the reduction of risk conferred by high-flux membranes. In summary, we did not detect a significant survival benefit with either high-flux or low-flux membranes in the population overall, but the use of high-flux membranes conferred a significant survival benefit among patients with serum albumin
4 g/dl. The apparent survival benefit among patients who have diabetes and are treated with high-flux membranes requires confirmation given the post hoc nature of our analysis.
Related Articles
J. Am. Soc. Nephrol. 2009 20: 462-464.
J. Am. Soc. Nephrol. 2009 20: A12.
This article has been cited by other articles:
![]() |
I. Ledebo and P. J. Blankestijn Haemodiafiltration--optimal efficiency and safety NDT Plus, February 1, 2010; 3(1): 8 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Penne, N. C. van der Weerd, P. J. Blankestijn, M. A. van den Dorpel, M. P.C. Grooteman, M. J. Nube, P. M. ter Wee, R. Levesque, M. L. Bots, and on behalf of the CONTRAST investigators Role of Residual Kidney Function and Convective Volume on Change in {beta}2-Microglobulin Levels in Hemodiafiltration Patients Clin. J. Am. Soc. Nephrol., January 1, 2010; 5(1): 80 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tattersall, B. Canaud, O. Heimburger, L. Pedrini, D. Schneditz, W. Van Biesen, and European Renal Best Practice advisory Board High-flux or low-flux dialysis: a position statement following publication of the Membrane Permeability Outcome study Nephrol. Dial. Transplant., December 22, 2009; (2009) gfp626v1. [Full Text] [PDF] |
||||
![]() |
E. Vilar, A. C. Fry, D. Wellsted, J. E. Tattersall, R. N. Greenwood, and K. Farrington Long-Term Outcomes in Online Hemodiafiltration and High-Flux Hemodialysis: A Comparative Analysis Clin. J. Am. Soc. Nephrol., December 1, 2009; 4(12): 1944 - 1953. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Lameire, W. Van Biesen, and R. Vanholder Did 20 Years of Technological Innovations in Hemodialysis Contribute to Better Patient Outcomes? Clin. J. Am. Soc. Nephrol., December 1, 2009; 4(Supplement_1): S30 - S40. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Glassock, R. Pecoits-Filho, and S. H. Barberato Left Ventricular Mass in Chronic Kidney Disease and ESRD Clin. J. Am. Soc. Nephrol., December 1, 2009; 4(Supplement_1): S79 - S91. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vanholder, D. Abramowicz, J. B. Cannata-Andia, V. Cocchi, P. Cochat, A. Covic, K.-U. Eckardt, D. Fouque, O. Heimburger, S. Jenkins, et al. The future of European Nephrology 'Guidelines'--a declaration of intent by European Renal Best Practice (ERBP) NDT Plus, June 1, 2009; 2(3): 213 - 221. [Full Text] [PDF] |
||||
![]() |
A. K. Cheung and T. Greene Effect of Membrane Permeability on Survival of Hemodialysis Patients J. Am. Soc. Nephrol., March 1, 2009; 20(3): 462 - 464. [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673